DoseMe Joins Tabula Rasa HealthCare
In this article:
Tabula Rasa HealthCare (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, has completed its acquisition of DoseMe on January 2, 2019.
DoseMeRx’s precision dosing capabilities will join TRHC’s suite of technology and consulting services for healthcare organizations, CareVention Healthcare, a division focused on solutions to enhance and accelerate medication safety.
What does this mean for DoseMe customers?
The same team will continue to support our customers only now we have additional resources and capabilities to continue delivering value to health-systems around the world faster. Over 1,000 clinicians, across more than 100 locations world-wide, rely on DoseMeRx to optimize dosing of high-risk medications for tens of thousands of patients. This acquisition ensures we will continue to service and help more providers throughout the world.
What does this mean for DoseMe?
Our entire team is now part of the TRHC family! Charles Cornish, Chief Executive Officer of DoseMe, will be relocating to TRHC headquarters in Moorestown, New Jersey, United States. DoseMe’s founder, Robert McLeay will also continue with DoseMe as Chief Scientific Officer, remaining at our offices in Brisbane, Australia.
“We are excited to become part of TRHC and to be able to continue supporting our customers with exceptional service and innovative solutions to advance medication management and safety,” said Cornish.
To read more about the acquisition, the full press release is available at TRHC website.
About DoseMeRx
DoseMeRx is a precision dosing software designed for healthcare practitioners that uses Bayesian dosing methods to predict the optimal dose of drugs monitored by Therapeutic Drug Monitoring. It is unique support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, genotype (if available) and exact patient responses to the drug dosed (via drug concentrations) to guide dose optimization. Its simplicity and portability means Bayesian dosing benefits can be brought to every bedside. Try the full DoseMeRx platform including all drug packages free for 14 days.